SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-initiating cell, and its contribution to the malignant phenotype and genomic state. We examine the potential of adult lineage-restricted progenitors to induce fully penetrant GBM using CNS progenitor-specific inducible Cre mice to mutate Nf1, Trp53, and Pten. We identify two phenotypically and molecularly distinct GBM subtypes governed by identical driver mutations. We demonstrate that the two subtypes arise from functionally independent pools of adult CNS progenitors. Despite histologic identity as GBM, these tumor types are separable based on the lineage of the tumor-initiating cell. These studies point to the cell of origin as a major determi...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Primary glioblastomas are subdivided into several molecular subtypes. There is an ongoing debate ove...
The multiple cell types of brain and blood arise from pluripotent stem cells via progressively more ...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Tumor heterogeneity is a major obstacle for finding effective treatment of G...
Background: Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma ...
Glioblastoma multiforme (GBM) is the most common adult primary brain tumor and is comprised of a het...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
High-grade glioma, particularly, glioblastoma, is the most aggressive cancer of the central nervous ...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Primary glioblastomas are subdivided into several molecular subtypes. There is an ongoing debate ove...
The multiple cell types of brain and blood arise from pluripotent stem cells via progressively more ...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Tumor heterogeneity is a major obstacle for finding effective treatment of G...
Background: Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma ...
Glioblastoma multiforme (GBM) is the most common adult primary brain tumor and is comprised of a het...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
High-grade glioma, particularly, glioblastoma, is the most aggressive cancer of the central nervous ...
The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression a...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Primary glioblastomas are subdivided into several molecular subtypes. There is an ongoing debate ove...
The multiple cell types of brain and blood arise from pluripotent stem cells via progressively more ...